| Financial Year |
March 31 2023 |
| Monetary Funds |
534,482,750.61 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
379,744,759.59 |
| Advances to Suppliers |
12,649,331.36 |
| Other Receivables |
243,059,081.89 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
374,778,670.69 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
52,847,018.31 |
| Total Current Assets |
1,597,561,612.45 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
2,053,860.54 |
| Investment Properties |
1,666,704,854.97 |
| Fixed Assetes |
260,127,561.13 |
| Under-construction Projects |
24,917,147.56 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
74,846,141.73 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
35,617,446.57 |
| Deferred Income Tax Assets |
432,556,834.19 |
| Other Non-Current Assets |
2,688,528.13 |
| Sub-Total of Non-Current Assets |
2,519,393,861.14 |
| Total Assets |
4,116,955,473.59 |
| Short-Term Loans |
60,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
517,042,486.89 |
| Accounts Received In Advance |
-2,726,079.91 |
| Employee Compensation Payable |
36,869,523.92 |
| Taxes Payable |
-8,640,613.60 |
| Interest Payable |
1,103,427.78 |
| Dividend Payable |
-- |
| Other payables |
158,601,951.26 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
133,833,333.32 |
| Other Current Liabilities |
4,090,631.61 |
| Sub-Total of Current Liabilities |
988,119,202.22 |
| Long-term Loans |
830,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
58,333,333.35 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
898,477,055.76 |
| Total Liabilities |
1,886,596,257.98 |
| Paid-In Capital(Or Share Stock) |
1,824,667,620.00 |
| Capital Surplus |
1,770,538,177.16 |
| Surplus Reserve |
140,681,622.73 |
| LESS:Treasury Stock |
100,050,000.00 |
| Undistributed Profits |
-1,368,345,614.04 |
| Minority Stockholder's Interest |
-43,005,845.29 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,273,365,060.90 |
| Owner's Equity（Stockholder's Equity） |
2,230,359,215.61 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,116,955,473.59 |
